|
|
 |
|
<<back
|
next>>
|
| Skin
Disorders At Early And Intermediate Stages Of Disease(CD4+ COUNT
200-500 cells/mm3) |
| Seborrhoeic dermatitis |
This
type of eczema, seen in up to 85% of HIV-infected patients,
initially affects the scalp, face, neck, axillae and groin.
As the CD4 count declines the extent and severity of seborrhea
increase and the response to therapy decreases. Lesions may
also be psoriaform in morphology, leading to diagnostic confusion.
Treatment of seborrhoeic dermatitis involves the topical application
of low-to-midpotency corticosteroids. Topical preparations with
ketoconazole or sulfacetamide may also benefit some patients.
Shampoos containing selenium sulfide may be used daily, whereas
ketoconazole shampoo is used twice weekly. A topical corticosteroid
lotion or gel may be massaged into the scalp following shampooing. |
| Scabies |
Scabies presents in a typical
form when the CD4+ lymphocyte counts are greater than 200 cells/mm3.
Small pruritic papules and burrows are found in warm, moist
areas such as the axillae, interdigital web spaces, and buttocks
(Fig. 1). Therapy includes topical benzyl benzoate emulsion
and gamma benzene hexachloride. |
| Xerosis and acquired
ichthyosis |
| About
25-30% of HIV-infected patients have dry, pruritic, scaling
skin (xerosis). Occasionally, the scaling can be more severe
resembling 'fish scales' (ichthyosis). Treatment of these conditions
includes emollients and occasionally combination topical preparations
including 10% urea or 10-20% salicylic acid. |
| Herpes
zoster |
Herpes zoster in HIV-infected persons usually displays its typical
clinical appearance with groups of painful vesicles on an erythematous
base, located in dermatomal distribution. The CD4+ count is
usually 300-400 cells/mm3. At lower CD4+ cell counts, however,
there is greater risk of complicated zoster in which the lesions
may be haemorrhagic, multidermatomal, disseminated, or ulcerated
(Fig. 2). Recurrent herpes zoster appearing in different dermatomes
may also occur. Herpes may affect multiple dermatomes in HIV-infected
persons. Oral antiviral agents such as acyclovir are of benefit
if given within the first 72 hours of infection. The patient
may consult an ophthalmologist if there is suspicion of ocular
involvement. |
| Human papilloma viral infections |
| In HIV-infected patients there is an increased incidence
of warts on the hands and face and within the oropharynx. Shaving
may cause disease spread in male patients. Condyloma acuminata,
or venereal warts, are also common and such patients should
be monitored for rectal carcinoma, cervical intraepithelial
neoplasia (CIN), and cervical carcinoma. Warts and condylomata
are difficult to treat in patients with HIV infection and tend
to recur. For condyloma acuminata in males and non-pregnant
females, topical podophyllin at 1-2-weekly intervals can be
used. Cryotherapy is a treatment alternative and is used for
warts elsewhere. |
| Papulopruritic eruption |
| Studies from Africa have indicated that this skin disorder
tends to occur at higher CD4+ lymphocyte counts than in Europe
and North America. This HIV-specific rash consists of sterile
pruritic papules and pustules located mainly on the extensor
surfaces of the arms, dorsa of the hands, and trunk; there is
sparing of the palms and soles. The condition is chronic and
tends to wax and wane. Varying therapeutic success has been
achieved with ultraviolet light, antihistamines, and potent
topical corticosteroids. |
|